As of Apr 28
| -0.10 / -2.37%|
The 6 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 10.75, with a high estimate of 18.00 and a low estimate of 3.70. The median estimate represents a +160.92% increase from the last price of 4.12.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.